Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Authid Inc.

Start price
Target price
Perf. (%)
€32.80
21.03.22
€16.00
21.03.23
-91.02%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
buy
Lifeway Foods Inc.

Start price
Target price
Perf. (%)
€7.60
21.03.22
€7.00
21.03.23
-23.68%
22.03.23

Could be worthwhile Investment >10% per year
Innovative
Stable Large shareholder and/or long term investor
buy
micromobility.com Inc.

Start price
Target price
Perf. (%)
€149.00
21.03.22
-
21.03.23
1.34%
02.04.22

Good culture
Could be very worthwhile Investment >20% year
Very capable Management
Dependend from some customers or products
Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.09
21.03.22
€0.000
21.03.23
-30.06%
02.04.22

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Revenue decline/stagnation expected
EBIT decline > 20% expected
Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.09
21.03.22
-
21.03.23
-47.45%
22.03.23

Risky Investment
buy
Naked Brand Group Ltd.

Start price
Target price
Perf. (%)
€1.78
20.03.22
-
20.03.23
-77.97%
21.03.23

Could be very worthwhile Investment >20% year
Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
buy
Takkt AG

Start price
Target price
Perf. (%)
€15.44
19.03.22
€17.00
19.03.23
1.81%
04.04.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
buy
StoneCo Ltd

Start price
Target price
Perf. (%)
€12.50
19.03.22
-
19.03.23
-12.09%
01.04.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Higher risks for its business
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€1.95
19.03.22
€5.00
19.03.23
88.69%
20.03.23

Could be worthwhile Investment >10% per year
Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.33
18.03.22
-
18.03.23
-9.77%
18.03.22

Risky Investment
buy
Westport Innovations Inc.

Start price
Target price
Perf. (%)
€1.54
17.03.22
€2.00
20.02.23
1.34%
05.04.22

Innovative
Differentiated customer and product portfolio
Known brand
Very Future proof/growth oriented business model
buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€13.67
17.03.22
€75.00
17.04.22
20.73%
18.04.22

Could be very worthwhile Investment >20% year
buy
Hexagon Composites ASA

Start price
Target price
Perf. (%)
€3.41
17.03.22
€4.00
17.03.23
1.64%
19.03.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Datagroup AG

Start price
Target price
Perf. (%)
€87.50
17.03.22
-
17.03.23
-29.03%
16.11.22

buy
Marrone Bio Inn.

Start price
Target price
Perf. (%)
€0.94
16.03.22
€1.00
16.03.23
3.21%
17.03.23

Could be worthwhile Investment >10% per year
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.69
16.03.22
€1.90
16.03.23
-18.24%
28.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
buy
Baozun Inc ADR

Start price
Target price
Perf. (%)
€7.02
16.03.22
€7.00
16.03.23
-46.87%
26.11.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€2.93
16.03.22
€3.30
16.03.23
-19.74%
12.04.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€2.89
16.03.22
€3.60
16.03.23
-48.16%
21.07.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
SNP Schneider-Neureither & Partner AG

Start price
Target price
Perf. (%)
€29.12
16.03.22
€32.00
16.03.23
0.45%
17.03.23

high free float
Higher risks for its business
Very high cyclical dependencies
Little known brand
buy
Frequentis AG

Start price
Target price
Perf. (%)
€26.80
16.03.22
€34.00
16.03.23
16.79%
17.03.23

Future proof or reliable business model
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€21.29
16.03.22
€56.00
16.03.23
149.27%
17.03.23

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year